About
TellBio develops a proprietary circulating tumor cells (CTCs) technology platform, the TellDx CTC System, to enable improved detection and monitoring of cancer progression and to support development of novel anti-cancer therapies.
Explore TellBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.